Dasatinib Krka is a medicine used to treat certain blood cancers, such as chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), by stopping the growth of cancer cells.
The usual starting dose for adults is 100 mg once daily for chronic myeloid leukemia (CML) or 140 mg once daily for accelerated phase or acute lymphoblastic leukemia (ALL); children's dose is based on weight.
Take the tablets whole at the same time each day; do not crush, split, or chew them. You can take them with or without food.
Your doctor will determine your maximum daily dose based on your response to treatment.